Latest Articles

Publication Date
Garmin running watches start at $149 at Amazon in Dec. 2025 - Mashable

Garmin running watches start at $149 at Amazon in Dec. 2025 Mashable

Published: Dec. 5, 2025, 7:50 p.m.
Gwen Crabb: Wales lock joins Brython Thunder from Gloucester-Hartpury - BBC

Gwen Crabb: Wales lock joins Brython Thunder from Gloucester-Hartpury BBC

Published: Dec. 5, 2025, 3:36 p.m.
Walmart Cyber Monday 2025 deals still live: MacBooks, Switch bundles, Dyson vacuums - Mashable

Walmart Cyber Monday 2025 deals still live: MacBooks, Switch bundles, Dyson vacuums Mashable

Published: Dec. 5, 2025, 4:58 a.m.
Personalized Estimation of Fatigue in Endometriosis Using Wrist-Worn Actigraphy Data and Hierarchical Bayesian Modeling.

Endometriosis is a common chronic condition associated with debilitating pain and fatigue. Wearable technology has the potential to improve symptom monitoring in endometriosis where symptom severity has been traditionally evaluated …

Published: Dec. 5, 2025, midnight
UBE2S-mediated deubiquitination of GLUT1 via USP10 regulates glucose metabolic reprogramming and immune microenvironment to promote fibrosis in endometriosis.

Endometriosis (EM) is a chronic inflammatory disorder characterized by the growth of ectopic endometrial-like tissue and fibrosis. Metabolic reprogramming, particularly enhanced glycolysis, and immune microenvironment dysregulation are key features of …

Published: Dec. 5, 2025, midnight
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything - The Times of India

Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything The Times of India

Published: Dec. 4, 2025, 3:13 p.m.
Absci Announces First Participants Dosed In Phase 1/2A Headline Trial - TradingView

Absci Announces First Participants Dosed In Phase 1/2A Headline Trial TradingView

Published: Dec. 4, 2025, 1:24 p.m.
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia - The Manila Times

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia The Manila Times

Published: Dec. 4, 2025, 1:22 p.m.
Absci Announces First Participants Dosed in Phase 1/2a - GlobeNewswire

Absci Announces First Participants Dosed in Phase 1/2a GlobeNewswire

Published: Dec. 4, 2025, 1 p.m.
RETRACTED ARTICLE: Effects of Kuntai capsule on breast pain and vaginal bleeding in postmenopausal women.

Description Following a complaint and technical (editorial) investigation, the authors were requested to provide essential documentation to verify the reliability, validity, and ethical compliance of the study published. Despite repeated …

Published: Dec. 4, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!